U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541794) titled 'Relaxing Virtual Reality Use and Blood Glucose Response to Food (ReViR) Study' on Aug. 18, 2025.
Brief Summary: This randomized cross-over pilot clinical trial aims to evaluate the feasibility and effect of a relaxing virtual reality (VR) experience on glucose response after white bread consumption, compared to a stress-inducing VR, a VR clinical room, and a real clinical room, in healthy adults. Participants will use a head-mounted display to experience either one of the VR environments, or they will simply sit in an actual clinical room for 15 minutes. After this pre-meal condition, participants will consume 66 grams of white bre...